Literature DB >> 10991928

Methyl p-hydroxybenzoate (E-218) a preservative for drugs and food is an activator of the ryanodine receptor Ca(2+) release channel.

D Cavagna1, F Zorzato, E Babini, G Prestipino, S Treves.   

Abstract

1. Haloperidol is a drug used in the management of several psychotic disorders and its use has been linked to Neuroleptic Malignant Syndrome. In the present study we have investigated the effect of a commercial preparation of haloperidol, Serenase, on skeletal muscle sarcoplasmic reticulum. 2. Addition of Serenase to isolated terminal cisternae caused a rapid release of calcium. We tested whether the active Ca(2+)-releasing substance was haloperidol or another compound present in the preparation. 3. Our results show that methyl p-hydroxybenzoate, one of the preservatives and a commonly used anti-microbial agent (E-218) is an activator of Ca(2+) release (E.C. 50=2.0 mM), mediated by a ruthenium red-sensitive Ca(2+) release channel present in skeletal muscle terminal cisternae.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10991928      PMCID: PMC1572324          DOI: 10.1038/sj.bjp.0703571

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  Drug-induced Ca2+ release from isolated sarcoplasmic reticulum. II. Releases involving a Ca2+-induced Ca2+ release channel.

Authors:  P Palade
Journal:  J Biol Chem       Date:  1987-05-05       Impact factor: 5.157

2.  Direct photoaffinity labeling of junctional sarcoplasmic reticulum with [14C]doxorubicin.

Authors:  F Zorzato; A Margreth; P Volpe
Journal:  J Biol Chem       Date:  1986-10-05       Impact factor: 5.157

3.  Neuroleptic malignant syndrome induced by a single injection of haloperidol.

Authors:  F Konikoff; A Kuritzky; Y Jerushalmi; E Theodor
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-03

4.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

Review 5.  Pharmacology of calcium release from sarcoplasmic reticulum.

Authors:  P Palade; C Dettbarn; D Brunder; P Stein; G Hals
Journal:  J Bioenerg Biomembr       Date:  1989-04       Impact factor: 2.945

6.  Skeletal muscle type ryanodine receptor is involved in calcium signaling in human B lymphocytes.

Authors:  Y Sei; K L Gallagher; A S Basile
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

7.  Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2.

Authors:  T V McCarthy; J M Healy; J J Heffron; M Lehane; T Deufel; F Lehmann-Horn; M Farrall; K Johnson
Journal:  Nature       Date:  1990-02-08       Impact factor: 49.962

8.  Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia.

Authors:  D H MacLennan; C Duff; F Zorzato; J Fujii; M Phillips; R G Korneluk; W Frodis; B A Britt; R G Worton
Journal:  Nature       Date:  1990-02-08       Impact factor: 49.962

9.  Preparation and morphology of sarcoplasmic reticulum terminal cisternae from rabbit skeletal muscle.

Authors:  A Saito; S Seiler; A Chu; S Fleischer
Journal:  J Cell Biol       Date:  1984-09       Impact factor: 10.539

10.  Single channel measurements of the calcium release channel from skeletal muscle sarcoplasmic reticulum. Activation by Ca2+ and ATP and modulation by Mg2+.

Authors:  J S Smith; R Coronado; G Meissner
Journal:  J Gen Physiol       Date:  1986-11       Impact factor: 4.086

View more
  4 in total

1.  Altered elementary calcium release events and enhanced calcium release by thymol in rat skeletal muscle.

Authors:  Péter Szentesi; Henrietta Szappanos; Csaba Szegedi; Monika Gönczi; István Jona; Julianna Cseri; László Kovács; László Csernoch
Journal:  Biophys J       Date:  2004-03       Impact factor: 4.033

2.  Functional properties of ryanodine receptors carrying three amino acid substitutions identified in patients affected by multi-minicore disease and central core disease, expressed in immortalized lymphocytes.

Authors:  Sylvie Ducreux; Francesco Zorzato; Ana Ferreiro; Heinz Jungbluth; Francesco Muntoni; Nicole Monnier; Clemens R Müller; Susan Treves
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

3.  Methyl p-hydroxybenzoate causes pain sensation through activation of TRPA1 channels.

Authors:  F Fujita; T Moriyama; T Higashi; A Shima; M Tominaga
Journal:  Br J Pharmacol       Date:  2007-03-12       Impact factor: 8.739

4.  Effects of methyl p-hydroxybenzoate (methyl paraben) on Ca2+ concentration and histamine release in rat peritoneal mast cells.

Authors:  Sanae Fukugasako; Shinichi Ito; Yoshimi Ikemoto
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.